Related Experiment Videos
Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
Obstetrics and Gynecology
|September 1, 1987
Summary
This study reveals a continuous spectrum of prolactin (PRL) secretion in women, linking basal PRL levels to responses to stimuli like thyrotropin-releasing hormone. This clarifies hyperprolactinemia diagnosis and management.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Hormone Physiology
Background:
- Hyperprolactinemia, characterized by elevated prolactin (PRL) levels, affects women's reproductive health.
- Understanding the spectrum of lactotroph activity is crucial for accurate diagnosis and treatment.
- Idiopathic hyperprolactinemia presents diagnostic challenges due to its heterogeneous nature.
Purpose of the Study:
- To investigate the relationship between basal prolactin levels and hormonal responses to stimuli in women.
- To delineate the spectrum of lactotroph function in regularly menstruating women and those with hyperprolactinemia.
- To clarify the diagnostic utility of PRL and TSH responses in managing hyperprolactinemia.
Main Methods:
- Studied basal prolactin (PRL) levels over five days in 75 regularly menstruating women and 44 with hyperprolactinemia.
- Assessed PRL responses to thyrotropin-releasing hormone (TRH) and domperidone.
- Measured thyroid-stimulating hormone (TSH) responses to domperidone.
Main Results:
- Hormonal responses to TRH and domperidone correlated continuously with basal PRL levels across the entire sample.
- Diagnostic information from PRL responses to TRH and domperidone is limited in macroprolactinemia cases.
- A continuous spectrum of lactotroph activity was observed, from normal secretion to prolactinomas.
Conclusions:
- Hyperprolactinemia exists on a continuous spectrum of lactotroph activity, not distinct categories.
- Idiopathic hyperprolactinemia is heterogeneous, encompassing intermediate hypersecretors, macroprolactinemia, and undiagnosed prolactinomas.
- Basal PRL levels are key, with stimuli offering limited additional diagnostic value in specific hyperprolactinemia subtypes.